Basel III change how gold is classified globally. Central banks used to not be able to lend against the full value market value, but now they can. This is displacing US treasurys

---

It’s already gone through HHS review and the DEA is in the rulemaking phase. It wouldn’t even require an executive order since it’s an administrative process under the Controlled Substances Act. Important to note though; ONLY changing the scheduling to Schedule III does not change whether it’s legal to sell or possess large amounts of marijuana without a DEA license. Schedule III status means it can be prescribed if approved by the FDA (same as codeine or ketamine for medicinal use) and this would not violate federal law. Currently states that marijuana is legal in, technically it’s still illegal, the states and the fed are just not enforcing the laws on the books. Recreational use, possession, or sale outside the medicinal or research framework implied by changing the schedule of the drug would still violate federal law unless they change that specifically. As far as I know anyways. Regardless, it’ll be a huge step on the road to full legalization. Also the vast majority of Americans support this… just a bunch of these old ass politicians are too scared to publicly support it so they keep kicking the can down the road. There’s been studies on how much the healthcare system could save by using marijuana, so there are logical reasons for it to happen beyond just public support.

---

#TLDR --- Ticker: MSOS Direction: High as a kite Prognosis: Trump is going to reschedule marijuana to a Schedule III drug, giving US weed companies access to banking and tax breaks. This will send the ETF to the moon, past its 2021 highs of $50. Catalyst: Rescheduling by EOY 2025 or early 2026. Position: 4,000 shares and 6x $4c expiring Jan 2026

---